Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Shares in Vertex have soared after the company announced that tens of thousands of cystic fibrosis (CF) patients could benefit from treatment for the first time. The company is a pioneer in bringing ...

Dec 6 (Reuters) - Vertex Pharmaceuticals (VRTX.O), opens new tab said on Saturday its gene therapy helped children aged between 5 and 11 years with sickle cell disease to be free of painful events and ...

Vertex Pharmaceuticals dominates the cystic fibrosis treatment market and recently has expanded into other therapeutic areas. The biotech predicts full-year 2025 revenue of as much as $12 billion.

A veteran trader warned that Bitcoin’s parabola breakdown could be followed by an 80% price correction. Will history repeat itself, or will institutional investors defy the trend this time?

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Dr. JeFreda R. Brown is a financial ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Broad form insurance provides coverage for uncommon or higher-risk events, which is why it ...

After a full year of hectic news, original trends and nonstop content, Merriam-Webster has summed it all perfectly in one word: “slop.” On Dec. 15, Merriam-Webster announced “slop” as the 2025 Word of ...

The Federal Government is composed of three distinct branches: legislative, executive, and judicial, whose powers are vested by the U.S. Constitution in the Congress, the President, and the Federal ...